Bio Medica Laboratories Limited SME IPO: Price, GMP, Dates & Review

By /
Bio Medica Laboratories Limited SME IPO
BM
Bio Medica Laboratories Limited IPO
Pharmaceutical Formulations · Contract Manufacturing · Indore Facilities · GMP Certified
📋 SME IPO Fresh Issue cum OFS NSE SME
₹139
Upper Price
₹52.43 Cr
Issue Size
May 29, 2026
Listing Date
₹174.79 Cr
Market Cap
📅 IPO Timetable
All dates tentative
🟢
IPO Opens
Thursday, 21 May 2026
Bidding starts — apply before close
🔒
IPO Closes
Monday, 25 May 2026
Last day to bid — closes at 5:00 PM IST
📊
Tuesday, 26 May 2026
Allotment finalised by registrar
🔄
Wednesday, 27 May 2026
Unallotted funds returned; shares credited to demat
🏷️
Friday, 29 May 2026
Trading begins from 10:00 AM IST
📋 IPO Details
IPO Open Date21 May 2026 (Thu)
IPO Close Date25 May 2026 (Mon)
Listing Date29 May 2026 (Fri)
Face Value₹10 per share
Price Band₹132 to ₹139
Issue Price (Upper Band)₹139 per share
Issue TypeBook Build — Fresh cum OFS
Lot Size1,000 shares
Total Issue Size37,72,000 shares (₹52.43 Cr)
Fresh Issue33,95,000 shares (₹47.19 Cr)
Offer for Sale3,77,000 shares (₹5.24 Cr)
Market Maker Shares1,89,000 shares
Pre-Issue Shares91,80,001
Post-Issue Shares1,25,75,001
Promoter Holding (Pre)99.99%
Lead ManagerNarnolia Financial Services Ltd.
RegistrarSkyline Financial Services Pvt.Ltd.
💰 Lot Size & Minimum Investment
At upper price ₹139
Investor TypeLotsSharesAmount
Retail — Minimum & Maximum22,000₹2,78,000
S-HNI (sNII) — Min33,000₹4,17,000
S-HNI (sNII) — Max77,000₹9,73,000
B-HNI (bNII) — Min88,000₹11,12,000
⚠️ SME IPO Note: Minimum application for retail is 2 lots (2,000 shares = ₹2,78,000). Retail maximum limit is also 2 lots. Lot size is 1,000 shares; bids must be in multiples thereof.
👥 Investor Reservation
Total 37,72,000 shares
1.00%
QIB Portion
36,000 shares
50.01%
Retail (RII)
17,92,000 shares
48.98%
NII / HNI
17,55,000 shares
💡 Market Maker: Prabhat Financial Services Ltd. has been allocated 1,89,000 shares (5.01% of issue) to ensure liquidity post-listing.
📊 Live Subscription Status
Awaiting Bidding
Subscription data will be available once bidding begins on May 21, 2026. Check back for live updates from 10:00 AM IST.
📈 Company Financials
Restated · ₹ Crore
Metric30 Nov 202531 Mar 202531 Mar 202431 Mar 2023
Total Assets65.1739.1219.5317.57
Total Income28.6338.3315.3416.25
PAT8.669.792.500.33
EBITDA13.4515.215.631.70
Net Worth17.1214.734.942.44
Total Borrowing38.1715.0110.499.61
Income Growth
FY 2023–24₹15.34 Cr
FY 2024–25₹38.33 Cr
H1 FY26 (Nov 2025)₹28.63 Cr
🎯 Key Performance Indicators
99.59%
ROE
FY 2024–25
48.20%
ROCE
FY 2024–25
25.64%
PAT Margin
FY 2024–25
1.02
Debt/Equity
FY 2024–25
54.41%
ROE (H1 FY26)
Nov 30, 2025
23.22%
ROCE (H1 FY26)
Nov 30, 2025
30.35%
PAT Margin
Nov 30, 2025
8.66x
Price/Book
Nov 30, 2025
⚖️ Valuation & EPS
Pre-IPO EPS
₹10.67
FY25 earnings / pre-issue shares
P/E: 13.03x
Post-IPO EPS
₹10.33
Annualised H1 FY26 / post-issue shares
P/E: 13.45x
Price to Book Value
8.66x
At upper price band (FY25 book)
Market Cap (Post-IPO)
₹174.79 Cr
At issue price ₹139
ℹ️ Pre-IPO EPS (₹10.67) based on pre-issue shareholding (91,80,001) and FY25 earnings. Post-IPO EPS (₹10.33) based on post-issue shareholding (1,25,75,001) and annualised H1 FY26 earnings.
🎯 Objects of the Issue
Net proceeds utilisation
1
Repayment of loan
₹6.50 Cr
2
Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises
₹28.50 Cr
Total Net Proceeds Target ₹35.00 Cr
🏢 About Bio Medica Laboratories Limited
Est. 2015 · Indore, Madhya Pradesh · Pharma Formulations

Bio Medica Laboratories Limited specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable formats. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.

The company operates on a B2B model, focusing exclusively on contract manufacturing to develop formulations tailored to company specifications. Certified with GMP and GLP certificates by the Food & Drugs Administration of Madhya Pradesh, it delivers comprehensive pipelines from its two manufacturing facilities in Indore.

Competitive Strengths
✅Multi-product capability and diversified product portfolio
📍Experienced promoters, management team and technical employees
📋Strict quality assurance and compliance under GMP/GLP mandates
👨‍💼Established and long-standing B2B client relationships across segments
Company Promoters
MM
Mr. Mukesh Mehta
Promoter, Bio Medica Laboratories Limited
PM
Mr. Pradeep Mehta
Promoter, Bio Medica Laboratories Limited
📅 Key Dates
IPO Opens21 May 2026
IPO Closes25 May 2026
Allotment26 May 2026
Refund & Share Credit27 May 2026
Listing Day29 May 2026
💡 Quick Summary
Price Band₹132 – ₹139
Issue Price₹139 / share
Lot Size1,000 shares
Min. Investment (Retail)₹2,78,000 (2 lots)
Issue Size₹52.43 Cr
ListingNSE SME
🏦 Registrar & Lead Manager
Registrar
Skyline Financial Services Pvt.Ltd.
📞 02228511022
[email protected]
Lead Manager
Narnolia Financial Services Ltd.
Market Maker
Prabhat Financial Services Ltd.
📍 Registered Address
Bio Medica Laboratories Ltd.
Plot No. 11B-11C, Sector-E, Sanwer Road
Industrial Area, Industrial Estate (Indore),
Indore, Madhya Pradesh — 452015
📞 +91 7314102751
[email protected]
🛡️ Regulatory Note: SME IPO investments are subject to SEBI regulations. Always read the Prospectus/RHP before applying. Consult a SEBI-registered advisor before investing.
⚠️ Disclaimer: This page presents publicly available information from the Bio Medica Laboratories IPO RHP for informational purposes only. It does not constitute investment advice. IPO investments are subject to market risk. Please read all offer documents and consult a SEBI-registered advisor before investing.
📊
Track Bio Medica Laboratories Limited SME IPO: Price, GMP, Dates & Review GMP
Check real-time grey market premium, daily GMP history & estimated listing price.
Check GMP →

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top